Nifty

:

14644.70

Sensex

:

49792.12

123.55 (0.85%)
393.83 (0.80%)

Login

Nifty
Sensex

:
:

14644.70
49792.12

123.55 (0.85%)
393.83 (0.80%)

IOL Chemicals & Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - API

Rating :

80/99

BSE: 524164 | NSE: IOLCP

Watchlist

NSE BSE

710.30

19-Jan-2021

Open
High
Low
Previous Close

709.00
721.00
706.05
702.00

Volume
Traded Value (lacs)
52 Week High
52 Week Low

143842
1026.17
898.90
146.30

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,168.09
9.41
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,069.43
0.42%
3.81

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

17.14
26.69
24.43

EBITDA CAGR (%)

10 Years
5 Years
3 Years

23.83
62.03
36.86

PAT CAGR (%)

10 Years
5 Years
3 Years

50.21
-
135.39

P:E (Median)

8 Years
5 Years
3 Years

9.86
9.34
9.75

P:BV (Average)

8 Years
5 Years
3 Years

3.52
3.52
3.52

EV:EBITDA (Average)

8 Years
5 Years
3 Years

9.29
9.19
5.63

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 533.48 448.96 18.83% 460.11 492.80 -6.63% 441.46 422.29 4.54% 511.25 478.29 6.89%
Expenses 362.18 316.04 14.60% 307.99 348.19 -11.55% 304.61 265.15 14.88% 351.75 342.78 2.62%
EBITDA 171.30 132.92 28.87% 152.12 144.61 5.19% 136.85 157.14 -12.91% 159.50 135.51 17.70%
EBIDTM 32.11% 29.61% 7.67% 29.34% 31.00% 37.21% 31.20% 28.33%
Other Income 4.48 3.39 32.15% 5.80 3.32 74.70% 5.35 2.20 143.18% 3.96 0.85 365.88%
Interest 1.11 6.09 -81.77% 1.82 8.32 -78.12% 2.76 8.83 -68.74% 3.76 12.85 -70.74%
Depreciation 9.62 8.84 8.82% 9.36 8.59 8.96% 9.36 7.99 17.15% 8.94 8.38 6.68%
PBT 165.05 121.38 35.98% 146.74 131.02 12.00% 130.08 142.52 -8.73% 150.76 115.13 30.95%
Tax 38.09 33.68 13.09% 19.20 45.70 -57.99% 39.82 40.87 -2.57% 52.75 32.89 60.38%
PAT 126.96 87.70 44.77% 127.54 85.32 49.48% 90.26 101.65 -11.21% 98.01 82.24 19.18%
PATM 23.80% 19.53% -1.60% 17.31% 20.45% 24.07% 19.17% 17.19%
EPS 21.63 14.94 44.78% 21.73 14.53 49.55% 15.38 17.32 -11.20% 16.70 14.01 19.20%

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,946.30 1,894.47 1,685.33 983.30 710.65 580.42 384.73 563.50 481.51 470.68 389.41 Net Sales Growth 5.64% 12.41% 71.40% 38.37% 22.44% 50.86% -31.72% 17.03% 2.30% 20.87% Cost Of Goods Sold 1,103.97 1,065.01 1,047.25 695.28 477.40 416.20 279.34 369.54 300.23 299.77 241.90 Gross Profit 842.33 829.46 638.08 288.02 233.25 164.21 105.38 193.97 181.28 170.91 147.51 GP Margin 43.28% 43.78% 37.86% 29.29% 32.82% 28.29% 27.39% 34.42% 37.65% 36.31% 37.88% Total Expenditure 1,326.53 1,320.59 1,275.68 863.77 608.45 529.04 373.46 467.75 392.47 402.09 321.70 Power & Fuel Cost - 65.12 63.94 45.66 37.45 46.57 48.58 45.27 45.12 48.32 34.90 % Of Sales - 3.44% 3.79% 4.64% 5.27% 8.02% 12.63% 8.03% 9.37% 10.27% 8.96% Employee Cost - 97.20 78.43 56.10 43.18 35.13 24.72 27.08 22.08 20.14 17.01 % Of Sales - 5.13% 4.65% 5.71% 6.08% 6.05% 6.43% 4.81% 4.59% 4.28% 4.37% Manufacturing Exp. - 28.37 25.68 22.57 16.77 8.83 4.55 6.46 7.95 11.07 6.26 % Of Sales - 1.50% 1.52% 2.30% 2.36% 1.52% 1.18% 1.15% 1.65% 2.35% 1.61% General & Admin Exp. - 2.86 2.63 1.39 1.19 1.17 1.40 1.67 1.39 1.20 1.17 % Of Sales - 0.15% 0.16% 0.14% 0.17% 0.20% 0.36% 0.30% 0.29% 0.25% 0.30% Selling & Distn. Exp. - 48.45 46.72 33.73 20.81 12.81 6.39 11.27 0.00 0.00 0.00 % Of Sales - 2.56% 2.77% 3.43% 2.93% 2.21% 1.66% 2.00% 0% 0% 0% Miscellaneous Exp. - 13.58 11.03 9.04 11.65 8.33 8.48 6.47 15.70 21.58 0.00 % Of Sales - 0.72% 0.65% 0.92% 1.64% 1.44% 2.20% 1.15% 3.26% 4.58% 5.25% EBITDA 619.77 573.88 409.65 119.53 102.20 51.38 11.27 95.75 89.04 68.59 67.71 EBITDA Margin 31.84% 30.29% 24.31% 12.16% 14.38% 8.85% 2.93% 16.99% 18.49% 14.57% 17.39% Other Income 19.59 16.02 10.37 6.33 1.25 1.23 1.32 1.31 2.53 2.33 1.90 Interest 9.45 20.93 51.42 64.35 67.68 61.47 59.11 60.34 57.24 43.20 36.80 Depreciation 37.28 35.73 32.45 30.21 29.84 29.69 28.91 31.63 31.37 23.94 23.76 PBT 592.63 533.24 336.15 31.30 5.93 -38.55 -75.44 5.08 2.96 3.80 9.04 Tax 149.86 171.95 99.45 3.60 1.26 1.48 -8.79 1.78 1.37 -0.96 2.86 Tax Rate 25.29% 32.25% 29.59% 11.50% 21.25% -3.84% 11.65% 35.04% 46.28% -25.26% 31.64% PAT 442.77 361.29 236.70 27.70 4.67 -40.03 -66.65 3.30 1.59 4.75 6.18 PAT before Minority Interest 442.77 361.29 236.70 27.70 4.67 -40.03 -66.65 3.30 1.59 4.75 6.18 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 22.75% 19.07% 14.04% 2.82% 0.66% -6.90% -17.32% 0.59% 0.33% 1.01% 1.59% PAT Growth 24.06% 52.64% 754.51% 493.15% - - - 107.55% -66.53% -23.14% EPS 75.43 61.55 40.32 4.72 0.80 -6.82 -11.35 0.56 0.27 0.81 1.05

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 813.54 474.34 215.74 188.70 185.13 207.20 209.25 172.99 173.60 172.34 Share Capital 56.89 56.89 56.21 56.21 56.21 47.66 48.83 31.15 30.72 30.72 Total Reserves 747.33 408.13 159.53 132.49 128.92 153.56 160.42 141.84 142.45 139.52 Non-Current Liabilities 79.73 210.65 280.29 294.23 304.43 285.87 255.48 325.73 288.12 249.89 Secured Loans 0.00 189.88 236.16 262.37 283.25 253.84 163.91 202.96 198.26 179.76 Unsecured Loans 0.00 0.00 21.96 22.61 18.62 23.26 56.50 83.88 71.63 55.42 Long Term Provisions 3.85 4.59 2.04 1.50 1.18 0.30 0.30 0.13 0.12 0.33 Current Liabilities 459.40 324.79 350.97 327.67 282.92 208.54 276.82 228.54 225.83 180.64 Trade Payables 186.09 120.27 157.61 149.84 115.68 70.25 120.36 95.38 79.41 61.01 Other Current Liabilities 34.52 63.88 50.97 35.84 30.03 17.81 58.57 35.46 69.29 56.00 Short Term Borrowings 55.92 67.72 135.27 140.77 137.09 120.44 96.96 97.16 76.48 63.15 Short Term Provisions 182.87 72.92 7.12 1.22 0.13 0.04 0.94 0.54 0.65 0.48 Total Liabilities 1,352.67 1,009.78 847.00 810.60 772.48 701.61 741.55 727.26 687.55 602.87 Net Block 469.04 411.72 405.64 373.88 399.50 402.82 410.60 430.41 461.98 350.96 Gross Block 596.66 503.91 465.53 403.77 619.96 594.29 569.47 557.84 558.99 420.63 Accumulated Depreciation 127.62 92.19 59.89 29.89 220.47 191.47 158.86 127.42 97.01 69.67 Non Current Assets 504.62 457.60 416.02 395.94 415.63 418.12 460.38 475.91 487.70 424.74 Capital Work in Progress 19.19 27.02 6.95 21.26 4.31 4.21 33.06 31.51 12.38 56.80 Non Current Investment 0.00 0.00 0.00 0.05 0.04 0.04 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 10.58 11.56 1.26 0.38 9.01 10.75 13.08 11.92 11.01 15.12 Other Non Current Assets 5.81 7.30 2.17 0.37 2.77 0.30 3.63 2.07 2.34 1.86 Current Assets 848.05 552.18 430.98 414.66 356.86 283.49 281.17 251.35 199.85 178.12 Current Investments 0.05 0.06 0.06 0.05 0.05 0.01 0.00 0.00 0.00 0.00 Inventories 187.52 188.86 207.45 262.63 227.94 213.42 192.23 163.47 131.77 99.56 Sundry Debtors 278.13 199.16 146.14 112.77 87.26 32.67 49.26 35.82 21.59 31.14 Cash & Bank 154.65 29.60 17.32 16.81 11.94 12.70 11.45 12.39 8.70 18.08 Other Current Assets 227.70 7.62 3.22 3.61 29.67 24.68 28.25 39.66 37.80 29.36 Short Term Loans & Adv. 217.55 126.88 56.79 18.79 26.78 22.19 25.37 36.98 35.95 27.33 Net Current Assets 388.65 227.39 80.01 86.99 73.93 74.95 4.35 22.82 -25.97 -2.52 Total Assets 1,352.67 1,009.78 847.00 810.60 772.49 701.61 741.55 727.26 687.55 602.86

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 471.09 273.17 119.72 83.34 17.70 -46.96 78.40 53.19 54.91 23.64 PBT 533.24 336.15 31.30 5.93 -38.55 -75.44 5.08 2.96 3.80 9.04 Adjustment 51.61 82.35 91.64 95.92 83.92 81.73 86.38 83.25 63.48 57.02 Changes in Working Capital 3.39 -77.64 3.14 -17.45 -27.67 -52.83 -12.31 -32.25 -11.39 -39.97 Cash after chg. in Working capital 588.24 340.86 126.08 84.40 17.70 -46.54 79.15 53.96 55.89 26.09 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -117.15 -67.69 -6.36 -1.06 0.00 -0.42 -0.75 -0.76 -0.98 -2.44 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -184.52 -63.04 -50.38 -22.78 -27.37 -4.79 -12.12 -17.97 -86.88 -69.33 Net Fixed Assets -84.92 -58.45 -47.45 199.24 -25.77 4.03 -13.18 -17.98 -93.94 -58.08 Net Investments 0.01 0.00 0.04 -0.01 -0.04 -0.05 0.00 0.00 0.00 0.00 Others -99.61 -4.59 -2.97 -222.01 -1.56 -8.77 1.06 0.01 7.06 -11.25 Cash from Financing Activity -271.89 -197.46 -70.36 -59.78 9.27 49.69 -65.68 -31.80 23.05 59.02 Net Cash Inflow / Outflow 14.68 12.67 -1.02 0.78 -0.40 -2.07 0.60 3.42 -8.92 13.34 Opening Cash & Equivalents 13.41 0.74 1.76 0.98 1.38 15.06 14.46 11.03 19.94 6.60 Closing Cash & Equivalent 28.09 13.41 0.74 1.76 0.98 12.99 15.06 14.46 11.03 19.94

Financial Ratios

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 141.36 81.74 38.38 33.57 32.94 42.22 65.67 64.24 65.39 64.25 ROA 30.59% 25.50% 3.34% 0.59% -5.43% -9.24% 0.45% 0.22% 0.74% 1.11% ROE 56.93% 69.54% 13.70% 2.50% -20.72% -34.14% 1.85% 0.95% 2.85% 4.06% ROCE 68.09% 55.53% 15.03% 11.57% 3.68% -2.78% 11.48% 10.55% 8.72% 9.89% Fixed Asset Turnover 3.44 3.48 2.30 1.51 1.06 0.73 1.11 0.96 1.03 1.01 Receivable days 45.98 37.39 47.21 47.21 33.98 35.12 24.85 19.63 19.04 26.46 Inventory Days 36.26 42.92 85.71 115.79 125.04 173.90 103.91 100.92 83.51 71.90 Payable days 42.33 37.73 62.92 46.31 3.40 9.79 8.96 18.14 19.56 50.02 Cash Conversion Cycle 39.91 42.57 69.99 116.69 155.61 199.24 119.80 102.41 82.98 48.35 Total Debt/Equity 0.07 0.61 1.96 2.37 2.44 1.99 1.71 2.31 2.28 1.98 Interest Cover 26.48 7.54 1.49 1.09 0.37 -0.28 1.08 1.05 1.09 1.25

Top Investors:

vasudeva commercials limited

vasudeva fuels private limited

vasudeva organics private limited

g consultants and fabricators ltd

stichting depositary apg emerging markets equity pool

morgan stanley asia (singapore) pte. - odi

Annual Reports:

News Update:

IOL Chem & Pharma - Quarterly Results
6th Nov 2020, 13:50 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback